Dogwood Therapeutics, Inc. Stock Analysis & AI Score
Dogwood Therapeutics, Inc. (DWTX) has an ST Score of 47.3 (C+), driven by its Growth (A) and held back by its Momentum (D). Analysts rate it Buy.
Composite rating from 8 factors. Tap a factor to see the metrics behind its grade.
Company Information
| Employees | — |
| CEO | — |
| Sector | Healthcare |
| Industry | Biotechnology |
| IPO Date | — |
| Website | — |
| Country | — |
| Exchange | NASDAQ |
SEC Filings
Annual Report (10-K)
| Filing Date | Accepted | Link |
|---|---|---|
| Loading… | ||
Quarterly Report (10-Q)
| Filing Date | Accepted | Link |
|---|---|---|
| Loading… | ||
ST Score
Dogwood Therapeutics, Inc. (DWTX) has an ST Score of 47.3 (C+), driven by its Growth (A) and held back by its Momentum (D). Analysts rate it Buy.
- Strongest
- GrowthA
- Weakest
- MomentumD
All factor grades
- GrowthA
- ValuationB
- ProfitabilityB-
- Financial StrengthB-
- MomentumD
- Piotroski1/9
Contact
DWTX stock: frequently asked questions
What is DWTX's ST Score?
Dogwood Therapeutics, Inc. (DWTX) has an ST Score of 47.3 (C+), on our 0–100 scale where higher is stronger. The ST Score combines eight factor grades — valuation, profitability, financial strength, momentum, growth, forecast, sentiment and Piotroski — into a single A+ to F rating.
Is DWTX a buy, hold, or sell?
Analysts rate DWTX a Buy. Our ST Score grades it C+ (47.3/100). The ST Score is a data-driven signal, not a recommendation.
What are DWTX's factor grades?
Valuation B, Profitability B-, Financial Strength B-, Momentum D, Growth A.
What is DWTX's valuation grade?
Dogwood Therapeutics, Inc. (DWTX) earns a valuation grade of B, measured against Biotechnology peers. The valuation factor looks at multiples such as P/E, P/S, P/B, EV/EBITDA and free cash flow yield.
What is DWTX's growth grade?
Dogwood Therapeutics, Inc. (DWTX) earns a growth grade of A, measured against Biotechnology peers. The growth factor looks at revenue, earnings and cash flow growth over recent quarters and years.
What is DWTX's profitability grade?
Dogwood Therapeutics, Inc. (DWTX) earns a profitability grade of B-, measured against Biotechnology peers. The profitability factor looks at margins and returns such as gross margin, net margin, ROE and ROIC.
What is DWTX's financial strength grade?
Dogwood Therapeutics, Inc. (DWTX) earns a financial strength grade of B-, measured against Biotechnology peers. The financial strength factor looks at debt levels, liquidity and coverage ratios.
What is DWTX's Piotroski score?
Dogwood Therapeutics, Inc. (DWTX) has a Piotroski F-Score of 1 out of 9. The Piotroski score checks nine accounting signals covering profitability, leverage and operating efficiency; scores of 8–9 are considered strong and 0–2 weak.